JY BioMed is developing a versatile exosome platform that isolates and characterizes extracellular vesicles from multiple clinically relevant biological sources. These exosomes contain diverse bioactive molecules with regenerative, immunomodulatory, and anti-inflammatory potential, supporting applications in tissue repair, dermatological science, and next-generation regenerative medicine.

​

Complementing formulation development, JY BioMed is actively investigating exosome-mediated mechanisms—including intercellular communication, immune modulation, and extracellular matrix restoration—to enable scalable, cell-free therapeutic strategies. Our platform emphasizes controlled bioprocessing, quality consistency, and regulatory preparedness to support future clinical translation.